EBS Operating Cash Flow (Statement)
Emergent Biosolutions Inc · Operating Cash Flow (Statement)
EBS Operating Cash Flow (Statement)
Latest reported$56.10Mperiod ending
EBS Quarterly Cash from Operations ($4.07M → $56.10M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
EBS operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 56,100,000 | |
| -33,800,000 | |
| 77,700,000 | |
| -2,300,000 | |
| 106,400,000 | |
| -11,200,000 | |
| -79,900,000 | |
| 153,700,000 | |
| 47,500,000 | |
| -62,600,000 | |
| 32,100,000 | |
| 60,000,000 | |
| -114,400,000 | |
| -184,000,000 | |
| 92,800,000 | |
| -74,000,000 | |
| -15,600,000 | |
| -37,300,000 | |
| 329,000,000 | |
| 16,700,000 | |
| -29,700,000 | |
| 5,100,000 | |
| 245,100,000 | |
| 105,200,000 | |
| 127,900,000 | |
| 57,800,000 | |
| 122,100,000 | |
| -3,100,000 | |
| -35,800,000 | |
| 104,800,000 | |
| -165,764,000 | |
| 173,973,000 | |
| 34,582,000 | |
| -991,000 | |
| 78,951,000 | |
| 33,515,000 | |
| 54,002,000 | |
| 41,671,000 | |
| -9,174,000 | |
| 26,978,000 | |
| -2,112,000 | |
| 37,795,000 | |
| 3,070,000 | |
| 104,759,000 | |
| 2,503,000 | |
| -65,873,000 | |
| 51,821,000 | |
| 78,923,000 | |
| 10,819,000 | |
| -29,245,000 | |
| 8,641,000 | |
| 60,125,000 | |
| 32,828,000 | |
| -4,626,000 | |
| -41,986,000 | |
| 46,897,000 | |
| 18,912,000 | |
| 15,820,000 | |
| 38,564,000 | |
| 4,836,000 | |
| -6,752,000 | |
| -22,055,000 | |
| 24,178,000 | |
| 54,172,000 | |
| 3,792,000 | |
| 17,401,000 | |
| -23,287,000 | |
| 33,336,000 | |
| 45,908,000 | |
| -25,446,000 | |
| -11,939,000 | |
| 19,943,000 | |
| 4,341,000 | |
| -5,028,000 | |
| 79,142,000 | |
| -10,108,000 | |
| -28,373,000 | |
| 14,786,000 | |
| 4,065,000 |